# Thymic Atypical Carcinoid Mimicking Recurrent Type A Thymoma on Frozen Section: A Diagnostic Pitfall Resolved by Intraoperative Imprint Cytology

**Authors:** Thao T Nguyen, Kazuki Fujita, Motona Kumagai, Daisuke Hoshi, Sohsuke Yamada

PMC · DOI: 10.7759/cureus.103253 · Cureus · 2026-02-09

## TL;DR

A rare thymic tumor was initially mistaken for a different type during surgery but was correctly identified using additional tests, showing the importance of combining multiple diagnostic methods.

## Contribution

Demonstrates how intraoperative imprint cytology and immunohistochemistry can prevent misdiagnosis of thymic neuroendocrine neoplasms as type A thymoma.

## Key findings

- Frozen sections misdiagnosed the tumor as atypical type A thymoma.
- Imprint cytology and immunohistochemistry correctly identified it as thymic atypical carcinoid.
- The tumor showed high Ki-67 index and specific immunohistochemical markers.

## Abstract

Thymic neuroendocrine neoplasms (tNENs) are rare anterior mediastinal tumors with aggressive behavior and can be misdiagnosed as type A thymoma on small biopsies or intraoperative frozen sections, although accurate distinction is critical for prognosis and management. Type A thymoma, while generally considered a low-grade malignant tumor with a favorable prognosis, comprises a small subset that exhibits aggressive features and develops distant metastases after surgical resection; these tumors are classified as atypical type A thymomas. A 72-year-old woman had a history of resected atypical type A thymoma two years earlier. Surveillance computed tomography revealed a 15-mm mediastinal nodule located anterior to the superior vena cava with intense fluorodeoxyglucose uptake on positron emission tomography-computed tomography. Frozen sections showed a proliferation of small- to medium-sized polygonal and short spindle cells arranged in solid nests and trabeculae without a lymphocyte-rich background, and were interpreted as recurrent atypical type A thymoma. In contrast, imprint cytology demonstrated monomorphic small- to medium-sized tumor cells with round to oval nuclei, finely granular “salt-and-pepper” chromatin, inconspicuous nucleoli, loose cohesion, and scattered rosette-like structures, strongly suggesting a tNEN. Permanent sections revealed nests, trabeculae, and rosettes of small- to medium-sized polygonal cells with granular chromatin and approximately four mitoses per 10 high-power fields, without large confluent necrosis. Immunohistochemistry showed diffuse positivity for CD56, chromogranin A, synaptophysin, and insulinoma-associated protein 1; a Ki-67 index of about 20%; negativity for CD5, CD117 (c-KIT), p63 (TP63), CK5/6, and CD20; and the absence of TdT/CD99-positive immature T cells, supporting a diagnosis of thymic atypical carcinoid. This case highlights the complementary value of imprint cytology and an appropriate immunohistochemical panel, in addition to frozen sections, in avoiding misclassification of tNENs as type A thymoma.

## Linked entities

- **Genes:** NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684], CD5 (CD5 molecule) [NCBI Gene 921], KIT (KIT proto-oncogene, receptor tyrosine kinase) [NCBI Gene 3815], KIT (KIT proto-oncogene, receptor tyrosine kinase) [NCBI Gene 3815], RPE65 (retinoid isomerohydrolase RPE65) [NCBI Gene 6121], TP63 (tumor protein p63) [NCBI Gene 8626], ck56 (hypothetical protein) [NCBI Gene 310612231], MS4A1 (membrane spanning 4-domains A1) [NCBI Gene 931], DNTT (DNA nucleotidylexotransferase) [NCBI Gene 1791], CD99 (CD99 molecule (Xg blood group)) [NCBI Gene 4267]

## Full-text entities

- **Genes:** CD5 (CD5 molecule) [NCBI Gene 921] {aka LEU1, T1}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, CD99 (CD99 molecule (Xg blood group)) [NCBI Gene 4267] {aka HBA71, MIC2, MIC2X, MIC2Y, MSK5X}, KIT (KIT proto-oncogene, receptor tyrosine kinase) [NCBI Gene 3815] {aka C-Kit, CD117, MASTC, PBT, SCFR}, TP63 (tumor protein p63) [NCBI Gene 8626] {aka AIS, B(p51A), B(p51B), EEC3, KET, LMS}, SYP (synaptophysin) [NCBI Gene 6855] {aka MRX96, MRXSYP, XLID96}, INSM1 (INSM transcriptional repressor 1) [NCBI Gene 3642] {aka IA-1, IA1}, CHGA (chromogranin A) [NCBI Gene 1113] {aka CGA, PHE5, PHES}, DNTT (DNA nucleotidylexotransferase) [NCBI Gene 1791] {aka TDT}
- **Diseases:** mediastinal tumors (MESH:D008479), malignant tumor (MESH:D009369), metastases (MESH:D009362), necrosis (MESH:D009336), Type A Thymoma (MESH:D013945), Thymic Atypical Carcinoid (MESH:D013953)
- **Chemicals:** fluorodeoxyglucose (MESH:D019788)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12884195/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12884195/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12884195/full.md

---
Source: https://tomesphere.com/paper/PMC12884195